Daniel Etra: A Driving Force in Epi One’s Mission
At Epi One, our board of directors is more than a governance body. It is a powerhouse of experience, innovation, and mission-driven leadership. Each member brings ...
Read More The Early Detection Challenge: A Systems Problem Not a Lab Problem
At Epi One, we are often asked: “When will technology finally solve the challenge of early cancer detection?” The truth is, it already has. We now ...
Read More Nemours 2025 Gala Supports Pediatric Cancer Research
Epi One CEO Michael Marquardt recently had the honor of attending the annual gala of the Nemours Children’s Health System with his wife Claire, who serves ...
Read More Epi One Debuts Early Detection Assay Data at AACR 2025 Annual Meeting
Last week marked a milestone for Epi One: we presented for the first time at the American Association for Cancer Research (AACR) Annual Meeting in Chicago — ...
Read More American Cancer Society Medal of Honor Ceremony
Epi One CEO Michael Marquardt had the privilege of attending the American Cancer Society Medal of Honor ceremony in Washington, D.C. recently. The Award is ACS' ...
Read More Epi One March Update
Epi One CEO Michael Marquardt provides an update on the latest news on developments in our current laboratory, our search for additional lab space in Delaware, ...
Read More Epi One to Present Poster Session at AACR Conference
We are delighted to confirm that we will be presenting a poster session at this year's American Association for Cancer Research conference, which runs from 25 ...
Read More Epi One Raises $2.1 Million in Successful Equity Crowdfunding Campaign
Epi One, a trailblazer in cancer diagnostics, is thrilled to announce the successful conclusion of its equity crowdfunding campaign on StartEngine, which raised an impressive $2.1 ...
Read More Transforming Early Cancer Detection: Latest Webinar Highlights
At Epi One, we're on a mission to revolutionize how cancer is detected and diagnosed. During our recent webinar, our CEO, Michael Marquardt, and fellow healthcare ...
Read More Interested in Learning More?
Sign up for our Insider Waiting List
Join our journey toward a future where cancer diagnosis is faster, more accurate, and more accessible than ever before.